Professional background

Tim Hodgson is consultant in oral medicine and medical director of specialist hospitals board.

He gained BDS from Guy’s Dental School in 1989. He returned to the United Medical and Dental schools in 1990 to study Medicine. It was during this period that he commenced research on the oral manifestations of HIV infection in Africa. He obtained MRCP(UK) in 1998. FDS RCS (Eng) was completed in the same year. He was appointed specialist registrar in Oral Medicine at the Eastman in 1999 and has subsequently spent further periods in Malawi. He has published more than 75 articles in peer reviewed journals.

He was awarded an honorary FGDP(UK) in March 2008 in recognition of developing Structured Clinical Reasoning for the new MJDF. He is medical emergencies lead for the ORE for the GDC. He presently sits on steering for the 7th World Workshop for Oral Medicine 2018 in Gothenburg. He has been treasurer for the European Association for Oral Medicine and a council member of the British Association. He has lectured across Europe Israel the Middle East India and Australia.

Specialties

Research interests

Oral manifestations of systemic disease, therapies for oral ulcerative disease, the oral disease psychology interface, paediatric oral medicine

Publications

  • Ni Riordain R, Christou J, Squires V, Hodgson TA. Cost-of-illness of oral lichen planus in a UK population – a pilot study. J Oral Pathol Med. 2016 Jan 11. doi: 10.1111/jop.12415. [Epub ahead of print]
  • Ni Riordain R, Hodgson TA, Porter SR Fedele S. Validity and reliability of the Chronic Oral Mucosal Diseases Questionnaire in a UK population. J Oral Pathol Med. 2016 Jan 26. doi: 10.1111/jop.12425. [Epub ahead of print]
  • Shephard MK, Nova CV, Thakrar P, Hodgson T. Checklists for safe prescribing in oral medicine clinics. Br Dent J. 2017 Dec;223(9):693-698. doi: 10.1038/sj.bdj.2017.887. Epub 2017 Oct 27.
  • Carey B, Lambourne J, Porter S, Hodgson T. Chronic Mucocutaneous Candidosis due to Gain-of-Function Mutation in STAT1. Oral Dis. 2019 Apr;25(3):684-692. doi: 10.1111/odi.12881. Epub 2018 Jun 8
  • Hong CHL, Dean DR, Hull K, Hu SJ, Sim YF, Nadeau C, Gonçalves S, Lodi G, Hodgson TA. World Workshop on Oral Medicine VII: Relative frequency of oral mucosal lesions in children, a scoping review. Oral Dis. 2019 Jun;25 Suppl 1:193-203. doi: 10.1111/odi.13112.
  • Wiriyakijja P, Porter SR, Fedele S, Hodgson T, McMillan R, Shephard M, Ni Riordain.R. Validation of the HADS and PSS-10 and Psychological Status in Patients With Oral Lichen Planus. Oral Dis. 2020 Jan;26(1):96-110. doi: 10.1111/odi.13220. Epub 2019 Nov 13.
  • Wiriyakijja P, Porter SR, Fedele S, Hodgson T, McMillan R, Shephard M, Ni Riordain.R. Development and validation of a short version of Chronic Oral Mucosal Disease Questionnaire (COMDQ-14). J Oral Pathol Med. 2020 Jan;49(1):55-62. doi: 10.1111/jop.12964. Epub 2019 Oct 28.
  • Wiriyakijja P, Porter SR, Fedele S, Hodgson T, McMillan R, Shephard M, Ni Riordain.R. Validation of the HADS and PSS-10 and a Cross-Sectional Study of Psychological Status in Patients with Recurrent Aphthous Stomatitis. J Oral Pathol Med. 2020 Mar;49(3):260-270. doi: 10.1111/jop.12991. Epub 2020 Jan 22.
  • Wiriyakijja P, Porter SR, Fedele S, Hodgson T, McMillan R, Shephard M, Ni Riordain.R. Meaningful Improvement Thresholds in Measures of Pain and Quality of Life in Oral Lichen Planus. Oral Dis. 2020 May 4. doi: 10.1111/odi.13379. Online ahead of print.
  • Harte MC; Saunsbury TA; Hodgson T. Thalidomide use in the management of oro-mucosal disease: A 10 year review of safety and efficacy in 12 patients. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Jun 17:S2212-4403(20)31063-4. doi: 10.1016/j.oooo.2020.06.009. Online ahead of print.